US Patent Issued to New Jersey Institute of Technology on June 17 for "Targeted nanoparticle for the treatment of traumatic brain injury and other CNS diseases" (New Jersey Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,765, issued on June 17, was assigned to New Jersey Institute of Technology (Newark, N.J.).

"Targeted nanoparticle for the treatment of traumatic brain injury and other CNS diseases" was invented by Venkatesan Perumal (Newark, N.J.), Arun Reddy Ravula (Newark, N.J.), Namas Chandra (Newark, N.J.), Venkata Kakulavarapu RamaRao (Newark, N.J.), Vivek Kumar (Newark, N.J.) and Zain Siddiqui (Paterson, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A composition, and method for a targeted drug delivery is disclosed in treating central nervous system injury, including blast hearing loss, traumatic brain injury (TBI) and the like, by administering a subj...